Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: Comparison of intermediate-term results

Transplantation

Volumn 95, Issue 3, 2013, Pages 489-494

  Bazerbachi, Fateh ^a   Selzner, Markus ^a   Marquez, Max A ^a   Norgate, Andrea ^a   McGilvray, Ian D ^a   Schiff, Jeffrey ^a   Cattral, Mark S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Insulin dependent diabetes mellitus; Intermediate term outcomes; Pancreas after kidney transplantation; Synchronous pancreas kidney transplantation

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; DELAYED GRAFT FUNCTION; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLYCEMIC CONTROL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART INFARCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INDUCTION CHEMOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; KIDNEY ABSCESS; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LENGTH OF STAY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS ABSCESS; PANCREAS AFTER KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; SYNCHRONOUS PANCREAS KIDNEY TRANSPLANTATION; URINARY TRACT INFECTION; WOUND INFECTION;

ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84873407087     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318274ab1a     Document Type: Article

References (27)

1. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ 1998; 159: S1.
2. Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463.
3. Humar A, Ramcharan T, Kandaswamy R, et al. Pancreas after kidney transplants. Am J Surg 2001; 182: 155.
4. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Clin Transpl 2008: 45.
5. International Pancreas Transplant Registry. Minneapolis, MN: Univesrity of Minnesota Department of Surgery; 2004: 16(1).
6. Abouljoud MS, Deierhoi MH, Hudson SL, et al. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy. Transplantation 1995; 60: 138.
7. Venstrom JM, McBride MA, Rother KI, et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290: 2817.
8. OPTN/SRTR Data as of May 1, 2008.
9. Fridell JA, Mangus RS, Hollinger EF, et al. The case for pancreas after kidney transplantation. Clin Transplant 2009; 23: 447.
10. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transplant 2005; 1.
11. Kasiske BL, Snyder JJ, Matas AJ, et al. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol 2002; 13: 1358.
12. Ojo AO, Meier-Kriesche HU, Arndorfer JA, et al. Long-term benefit of kidney-pancreas transplants in type 1 diabetics. Transplant Proc 2001; 33: 1670.
13. Kleinclauss F, Fauda M, Sutherland DE, et al. Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function. Clin Transplant 2009; 23: 437.
14. Weiss AS, Smits G, Wiseman AC. Twelve-month pancreas graft function significantly influences survival following simultaneous pancreaskidney transplantation. Clin J Am Soc Nephrol 2009; 4: 988.
15. Becker BN, Brazy PC, Becker YT, et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000; 57: 2129.
16. Gruessner RW, Sutherland DE, Gruessner AC. Survival after pancreas transplantation. JAMA 2005; 293: 675; author reply 675.
17. Humar A, Khwaja K, Ramcharan T, et al. Chronic rejection: the next major challenge for pancreas transplant recipients. Transplantation 2003; 76: 918.
18. Troppmann C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182: 285.
19. Hariharan S, Pirsch JD, Lu CY, et al. Pancreas after kidney transplantation. J Am Soc Nephrol 2002; 13: 1109.
20. Humar A, Kandaswamy R, Granger D, et al. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231: 269.
21. Larson TS, Bohorquez H, Rea DJ, et al. Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreaskidney transplantation. Transplantation 2004; 77: 838.
22. Bazerbachi F, Selzner M, Boehnert MU, et al. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome. Transplantation 2011; 92: 1039.
23. Cattral MS, Bigam DL, Hemming AW, et al. Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg 2000; 232: 688.
24. Martin X, Petruzzo P, Dawahra M, et al. Effects of portal versus systemic venous drainage in kidney-pancreas recipients. Transpl Int 2000; 13: 64.
25. Bazerbachi F, Selzner M, Marquez MA, et al. Portal venous versus systemic venous drainage of pancreas grafts: impact on long-term results. Am J Transplant 2012; 12: 226.
26. Drachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system. Transplantation 1997; 63: 1579.
27. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.